These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34882771)

  • 1. Underascertainment of COVID-19 cases among first responders: a seroepidemiological study.
    Backhaus I; Hermsen D; Timm J; Boege F; Lübke N; Göbels K; von der Lieth D; Dragano N
    Occup Med (Lond); 2022 Apr; 72(3):225-228. PubMed ID: 34882771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study.
    Backhaus I; Hermsen D; Timm J; Boege F; Lübke N; Degode T; Göbels K; Dragano N
    Public Health; 2022 Jun; 207():54-61. PubMed ID: 35490440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.
    McGuire SS; Klassen AB; Heywood J; Sztajnkrycer MD
    Prehosp Disaster Med; 2021 Apr; 36(2):131-134. PubMed ID: 33397545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020.
    Zhang X; Saade E; Noguez JH; Schmotzer C
    Public Health Rep; 2023; 138(1):140-148. PubMed ID: 36114657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
    Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
    Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
    BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibody seroprevalence among firefighters in Orange County, California.
    Vieira V; Tang IW; Bartell S; Zahn M; Fedoruk MJ
    Occup Environ Med; 2021 Nov; 78(11):789-792. PubMed ID: 34433659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak.
    Korona-Głowniak I; Mielnik M; Podgajna M; Grywalska E; Hus M; Matuska K; Wojtysiak-Duma B; Duma D; Glowniak A; Malm A
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.
    Nah EH; Cho S; Park H; Hwang I; Cho HI
    BMJ Open; 2021 Apr; 11(4):e049837. PubMed ID: 33895722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.
    Takayama Y; Komatsu T; Wada T; Nihonyanagi S; Hoshiyama T; Moriya T; Shimamura S; Kajigaya N; Naito M; Takeuchi O; Bando Y; Watanabe M; Iwamura M; Hanaki H
    J Nippon Med Sch; 2022 Nov; 89(5):513-519. PubMed ID: 35644553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seroprevalence among firefighters in Los Angeles, California.
    Mulligan K; Berg AH; Eckstein M; Hori A; Rodriguez A; Sobhani K; Toubat O; Sood N
    Occup Environ Med; 2022 May; 79(5):315-318. PubMed ID: 35074885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
    Davila-Siliezar P; Wer A; Barnoya J
    Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021.
    Kronfli N; Dussault C; Maheu-Giroux M; Halavrezos A; Chalifoux S; Sherman J; Park H; Del Balso L; Cheng MP; Poulin S; Cox J
    Clin Infect Dis; 2022 Aug; 75(1):e165-e173. PubMed ID: 35037053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.
    Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T
    Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.